Ultralife Statistics
Total Valuation
Ultralife has a market cap or net worth of $86.45 million. The enterprise value is $128.29 million.
| Market Cap | 86.45M |
| Enterprise Value | 128.29M |
Important Dates
The next confirmed earnings date is Friday, August 7, 2026, before market open.
| Earnings Date | Aug 7, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Ultralife has 16.66 million shares outstanding. The number of shares has decreased by -0.95% in one year.
| Current Share Class | 16.66M |
| Shares Outstanding | 16.66M |
| Shares Change (YoY) | -0.95% |
| Shares Change (QoQ) | +0.02% |
| Owned by Insiders (%) | 42.26% |
| Owned by Institutions (%) | 32.71% |
| Float | 9.62M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.46 |
| Forward PS | 0.50 |
| PB Ratio | 0.67 |
| P/TBV Ratio | 1.17 |
| P/FCF Ratio | 14.10 |
| P/OCF Ratio | 8.75 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.68 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 20.92 |
Financial Position
The company has a current ratio of 2.56, with a Debt / Equity ratio of 0.39.
| Current Ratio | 2.56 |
| Quick Ratio | 1.01 |
| Debt / Equity | 0.39 |
| Debt / EBITDA | n/a |
| Debt / FCF | 8.27 |
| Interest Coverage | -2.51 |
Financial Efficiency
Return on equity (ROE) is -6.23% and return on invested capital (ROIC) is 3.22%.
| Return on Equity (ROE) | -6.23% |
| Return on Assets (ROA) | 1.56% |
| Return on Invested Capital (ROIC) | 3.22% |
| Return on Capital Employed (ROCE) | -5.36% |
| Weighted Average Cost of Capital (WACC) | 7.56% |
| Revenue Per Employee | $277,077 |
| Profits Per Employee | -$12,115 |
| Employee Count | 678 |
| Asset Turnover | 0.85 |
| Inventory Turnover | 2.75 |
Taxes
| Income Tax | -3.21M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -36.78% in the last 52 weeks. The beta is 0.78, so Ultralife's price volatility has been lower than the market average.
| Beta (5Y) | 0.78 |
| 52-Week Price Change | -36.78% |
| 50-Day Moving Average | 6.17 |
| 200-Day Moving Average | 6.27 |
| Relative Strength Index (RSI) | 31.52 |
| Average Volume (20 Days) | 29,697 |
Short Selling Information
The latest short interest is 69,458, so 0.42% of the outstanding shares have been sold short.
| Short Interest | 69,458 |
| Short Previous Month | 70,437 |
| Short % of Shares Out | 0.42% |
| Short % of Float | 0.72% |
| Short Ratio (days to cover) | 2.76 |
Income Statement
In the last 12 months, Ultralife had revenue of $187.86 million and -$8.21 million in losses. Loss per share was -$0.49.
| Revenue | 187.86M |
| Gross Profit | 43.33M |
| Operating Income | 5.56M |
| Pretax Income | -11.51M |
| Net Income | -8.21M |
| EBITDA | -3.79M |
| EBIT | -9.52M |
| Loss Per Share | -$0.49 |
Balance Sheet
The company has $8.89 million in cash and $50.73 million in debt, with a net cash position of -$41.84 million or -$2.51 per share.
| Cash & Cash Equivalents | 8.89M |
| Total Debt | 50.73M |
| Net Cash | -41.84M |
| Net Cash Per Share | -$2.51 |
| Equity (Book Value) | 129.75M |
| Book Value Per Share | 7.78 |
| Working Capital | 67.05M |
Cash Flow
In the last 12 months, operating cash flow was $9.88 million and capital expenditures -$3.75 million, giving a free cash flow of $6.13 million.
| Operating Cash Flow | 9.88M |
| Capital Expenditures | -3.75M |
| Depreciation & Amortization | 5.47M |
| Net Borrowing | -6.13M |
| Free Cash Flow | 6.13M |
| FCF Per Share | $0.37 |
Margins
Gross margin is 23.06%, with operating and profit margins of 2.96% and -4.37%.
| Gross Margin | 23.06% |
| Operating Margin | 2.96% |
| Pretax Margin | -6.13% |
| Profit Margin | -4.37% |
| EBITDA Margin | -2.01% |
| EBIT Margin | -5.07% |
| FCF Margin | 3.26% |
Dividends & Yields
Ultralife does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.95% |
| Shareholder Yield | 0.95% |
| Earnings Yield | -9.50% |
| FCF Yield | 7.09% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Ultralife has an Altman Z-Score of 1.75 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.75 |
| Piotroski F-Score | 4 |